Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00726284 · ClinicalTrials.gov registry record

Spine Patient Outcomes Registry for Biomet/EBI (Electro-Biology, Inc)

A clinical trial of Degenerative Disc Disease and Spinal Stenosis, sponsored by Zimmer Biomet.

Completed
Registry status
651
Enrollment target
5
Study locations

NCT00726284 is a study of Degenerative Disc Disease and Spinal Stenosis that has completed, run by Zimmer Biomet. The registered enrollment target is 651 participants, above the 153-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (325% higher). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00726284, a study of Degenerative Disc Disease and Spinal Stenosis, has completed, sponsored by Zimmer Biomet.

COMPLETED
Registry status
651 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this patient registry is to prospectively collect data on patients who are having spinal surgery with EBI and Interpore Cross Spine Products.

Study Locations (5)

Arkansas

  • Neurological Surgery Associates - Little Rock

Florida

  • Florida Orthopedics Association - Orange City

Ohio

  • CNS Healthcare - Akron

Oklahoma

  • Oklahoma Spine and Brain - Tulsa

Pennsylvania

  • Pottstown Memorial Medical Center - Pottstown

Trial Details

FieldValue
Enrollment Target 651 participants
Start Date 2004-04
Est. Completion 2007-12-06

Sponsor

Zimmer Biomet

115 total trials

What the Registry Record Tells You About NCT00726284

The ClinicalTrials.gov registry entry for NCT00726284 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 651 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 153-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (325% higher). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Degenerative Disc Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00726284 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arkansas, Florida, Ohio.

Frequently Asked Questions

What is clinical trial NCT00726284 about?

NCT00726284 is a clinical study titled "Spine Patient Outcomes Registry for Biomet/EBI (Electro-Biology, Inc)". The purpose of this patient registry is to prospectively collect data on patients who are having spinal surgery with EBI and Interpore Cross Spine Products.

What is the current status of trial NCT00726284?

This trial is currently completed. The enrollment target is 651 participants. The study started on 2004-04. Estimated completion is 2007-12-06.

What conditions does trial NCT00726284 study?

This clinical trial studies the following conditions: Degenerative Disc Disease, Spinal Stenosis.

Who is sponsoring clinical trial NCT00726284?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00726284 being conducted?

This trial has 5 study locations across Arkansas, Florida, Ohio, Oklahoma, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Degenerative Disc Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.